日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview

探索非洲镰状细胞病的经济有效疗法:一项综合概述

Kassim, Adetola A; Thompson, Alexis A; Malik, Punam

Characterization of subclonal variants in HG002 Genome in a Bottle reference material as a resource for benchmarking variant callers

对HG002 Genome in a Bottle参考材料中的亚克隆变异进行表征,作为变异检测器基准测试的资源

Daniels, Camille A; Abdulkadir, Adetola A; Cleveland, Megan H; McDaniel, Jennifer H; Jáspez, David; Rubio-Rodríguez, Luis Alberto; Muñoz-Barrera, Adrián; Lorenzo-Salazar, José Miguel; Flores, Carlos; Yoo, Byunggil; Ebrahim Sahraeian, Sayed Mohammad; Wang, Yina; Rossi, Massimiliano; Visvanath, Arun; Murray, Lisa; Chen, Wei-Ting; Catreux, Severine; Han, James; Mehio, Rami; Parnaby, Gavin; Carroll, Andrew; Chang, Pi-Chuan; Shafin, Kishwar; Cook, Daniel; Kolesnikov, Alexey; Brambrink, Lucas; Eeman Mootor, Mohammed Faizal; Patel, Yash; Yamaguchi, Takafumi N; Boutros, Paul C; Sienkiewicz, Karolina; Foox, Jonathan; Mason, Christopher E; Lajoie, Bryan R; Ruiz-Perez, Carlos A; Kruglyak, Semyon; Zook, Justin M; Olson, Nathan D

SARS-CoV-2 vaccine safety and immunogenicity in patients with hematologic malignancies, transplantation, and cellular therapies

SARS-CoV-2疫苗在血液系统恶性肿瘤、移植和细胞疗法患者中的安全性和免疫原性

Ni, Bin; Yanis, Ahmad; Dee, Kevin; Chappell, James D; Dulek, Daniel E; Kassim, Adetola A; Kitko, Carrie L; Thomas, Lora D; Halasa, Natasha

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy

关于镰状细胞病治愈疗法的未来之争:单倍体造血干细胞移植与基因疗法

Kassim, Adetola A; Leonard, Alexis

Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic

在2019冠状病毒病(COVID-19)大流行期间,评估血液系统恶性肿瘤和干细胞移植患者的医疗相关感染率

Bobbitt, Laura J; Satyanarayana, Gowri; Van Metre Baum, Laura; Nebhan, Caroline A; Kassim, Adetola A; Gatwood, Katie S

Safety of 3 Tesla Magnetic Resonance Imaging in Patients with Sickle Cell Disease

3特斯拉磁共振成像在镰状细胞病患者中的安全性

Justice, Olivia; Jordan, Lori C; Lee, Chelsea A; Patel, Niral J; Waddle, Spencer; Pruthi, Sumit; Davis, L Taylor; Kassim, Adetola A; Donahue, Manus J

Improvement in processing speed following haploidentical bone marrow transplant with posttransplant cytoxan in children and adolescents with sickle cell disease

在患有镰状细胞病的儿童和青少年中,单倍体相合骨髓移植后使用移植后环磷酰胺可提高处理速度。

Prussien, Kemar V; Patel, Dilan A; Wilkerson, Karina; Armstrong, Becky; Karnik, Leena; de la Fuente, Josu; Kassim, Adetola A

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

代谢并发症先于同种异体反应发生,其特征是肿瘤发生抑制 2 信号传导发生改变

Johnpulle Romany A N, Paczesny Sophie, Jung Dae Kwang, Daguindau Etienne, Jagasia Madan H, Savani Bipin N, Chinratanalab Wichai, Cornell Robert F, Goodman Stacey, Greer John P, Kassim Adetola A, Sengsayadeth Salyka, Byrne Michael T, Engelhardt Brian G

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation

早期Th1免疫促进免疫耐受,并可能削弱同种异体造血干细胞移植后的移植物抗白血病效应。

Engelhardt, Brian G; Paczesny, Sophie; Jung, Dae Kwang; Daguindau, Etienne; Jagasia, Madan; Savani, Bipin N; Chinratanalab, Wichai; Cornell, Robert F; Goodman, Stacey; Greer, John P; Kassim, Adetola A; Sengsayadeth, Salyka; Yoder, Sandra M; Rock, Michael T; Crowe, James E Jr

How I treat and manage strokes in sickle cell disease

我如何治疗和管理镰状细胞病患者的中风

Kassim, Adetola A; Galadanci, Najibah A; Pruthi, Sumit; DeBaun, Michael R